Literature DB >> 10749369

An epitope shared by the hemagglutinins of H1, H2, H5, and H6 subtypes of influenza A virus.

Y A Smirnov1, A S Lipatov, A K Gitelman, Y Okuno, R Van Beek, A D Osterhaus, E C Claas.   

Abstract

The membrane-inserted hemagglutinin (HA) is the most variable protein of influenza viruses. Here we describe the characterization of a shared epitope in the HA of influenza A virus H1, H2, and H5 subtypes which were completely neutralized by a monoclonal antibody (MAb), directed against this epitope. This MAb (C179) also efficiently precipitated the HAs of these viruses. In addition, MAb C179 did not neutralize H6 subtype strains despite complete amino acid homology of the epitope regions. Furthermore, only the non-glycosylated form of the HA of one of the H6 subtype strains could be precipitated by the MAb. The conformational epitope may be masked by glycosylation, although it could not be excluded that differences in the primary amino acid sequence may cause the decreased accessibility of the epitope in H6 subtype strains.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10749369

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  34 in total

1.  Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.

Authors:  Jürgen A Richt; Porntippa Lekcharoensuk; Kelly M Lager; Amy L Vincent; Christina M Loiacono; Bruce H Janke; Wai-Hong Wu; Kyoung-Jin Yoon; Richard J Webby; Alicia Solórzano; Adolfo García-Sastre
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

2.  Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine.

Authors:  Davide Corti; Amorsolo L Suguitan; Debora Pinna; Chiara Silacci; Blanca M Fernandez-Rodriguez; Fabrizia Vanzetta; Celia Santos; Catherine J Luke; Fernando J Torres-Velez; Nigel J Temperton; Robin A Weiss; Federica Sallusto; Kanta Subbarao; Antonio Lanzavecchia
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

3.  Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design.

Authors:  Chih-Jen Wei; Jeffrey C Boyington; Kaifan Dai; Katherine V Houser; Melissa B Pearce; Wing-Pui Kong; Zhi-Yong Yang; Terrence M Tumpey; Gary J Nabel
Journal:  Sci Transl Med       Date:  2010-03-24       Impact factor: 17.956

4.  Structure, receptor binding, and antigenicity of influenza virus hemagglutinins from the 1957 H2N2 pandemic.

Authors:  Rui Xu; Ryan McBride; James C Paulson; Christopher F Basler; Ian A Wilson
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

5.  Antigenic characterization of recombinant hemagglutinin proteins derived from different avian influenza virus subtypes.

Authors:  Matthias Mueller; Sandra Renzullo; Roxann Brooks; Nicolas Ruggli; Martin A Hofmann
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

6.  Large-scale sequence analysis of hemagglutinin of influenza A virus identifies conserved regions suitable for targeting an anti-viral response.

Authors:  Leepakshi Sahini; Anna Tempczyk-Russell; Ritu Agarwal
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

7.  Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface.

Authors:  Seth J Zost; Jinhui Dong; Iuliia M Gilchuk; Pavlo Gilchuk; Natalie J Thornburg; Sandhya Bangaru; Nurgun Kose; Jessica A Finn; Robin Bombardi; Cinque Soto; Elaine C Chen; Rachel S Nargi; Rachel E Sutton; Ryan P Irving; Naveenchandra Suryadevara; Jonna B Westover; Robert H Carnahan; Hannah L Turner; Sheng Li; Andrew B Ward; James E Crowe
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 14.808

Review 8.  Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies.

Authors:  Peter S Lee; Ian A Wilson
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

9.  H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines.

Authors:  Xing Cheng; Michael Eisenbraun; Qi Xu; Helen Zhou; Deepali Kulkarni; Kanta Subbarao; George Kemble; Hong Jin
Journal:  PLoS One       Date:  2009-02-11       Impact factor: 3.240

10.  Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses.

Authors:  Jianhua Sui; William C Hwang; Sandra Perez; Ge Wei; Daniel Aird; Li-mei Chen; Eugenio Santelli; Boguslaw Stec; Greg Cadwell; Maryam Ali; Hongquan Wan; Akikazu Murakami; Anuradha Yammanuru; Thomas Han; Nancy J Cox; Laurie A Bankston; Ruben O Donis; Robert C Liddington; Wayne A Marasco
Journal:  Nat Struct Mol Biol       Date:  2009-02-22       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.